M. Bradley Drummond

2 weeks ago | ajmc.com | Pearl Steinzor |M. Bradley Drummond

Ensifentrine showed improved lung function, reduced exacerbations, and better patient-reported outcomes of breathing and overall chronic obstructive pulmonary disease (COPD) management, says M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill. The findings were presented at the American Thoracic Society (ATS) 2025 International Conference. This transcript was lightly edited; captions were auto-generated.